Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients

Clinical trial NCT07062263 · RECRUITING

Trial details

NCT number: NCT07062263
Sponsor: Tata Memorial Centre
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Biliary Tract Cancer HER2-positive Cancer Advanced Cancer Unresectable Biliary Tract Carcinoma Metastatic Biliary Tract Carcinoma

Start date: 2023-07-21
Primary completion: 2029-07-31
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.